Effects of adenosine nucleosides on adenylate cyclase, phosphodiesterase, cyclic adenosine monophosphate accumulation, and lipolysis in fat cells.
D000241:Adenosine / Q000494:pharmacology*; D000067956:Adenylyl Cyclase Inhibitors; D000273:Adipose Tissue / Q000166:cytology / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism; D000818:Animals; D001089:Arabinose / Q000494:pharmacology; D002462:Cell Membrane / Q000187:drug effects / Q000201:enzymology; D000242:Cyclic AMP / Q000378:metabolism*; D003839:Deoxyadenosines / Q000494:pharmacology; D004789:Enzyme Activation; D005246:Feedback; D005260:Female; D005461:Fluorine / Q000494:pharmacology; D008053:Lipid Mobilization / Q000187:drug effects*; D009638:Norepinephrine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D009705:Nucleosides / Q000494:pharmacology; D010726:Phosphodiesterase Inhibitors; D051381:Rats; D013806:Theophylline / Q000037:antagonists & inhibitors / Q000494:pharmacology; D014316:Tritium
D000067956:Adenylyl Cyclase Inhibitors; D003839:Deoxyadenosines; D009705:Nucleosides; D010726:Phosphodiesterase Inhibitors; D014316:Tritium; D005461:Fluorine; D001089:Arabinose; D013806:Theophylline; D000242:Cyclic AMP; D000241:Adenosine; D009638:Norepinephrine